Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

BACKGROUND: Peramivir offers a single‐dose intravenous (IV) treatment option for influenza (vs 5‐day oral dosing for oseltamivir). We sought to compare outcomes of emergency department (ED) patients at high risk for influenza complications treated with IV peramivir vs oral oseltamivir. METHODS: Duri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Influenza Other Respir Viruses
Main Authors: Hsieh, Yu‐Hsiang, Dugas, Andrea F., LoVecchio, Frank, McBryde, Breana, Ricketts, Erin P., Saliba‐Shaw, Kathryn, Rothman, Richard E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767951/
https://ncbi.nlm.nih.gov/pubmed/33006445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados